Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Zi Lin Huang"'
Autor:
Tian-Qi Zhang, Zhi-Jun Geng, Meng-Xuan Zuo, Ji-Bin Li, Jin-Hua Huang, Zi-Lin Huang, Pei-Hong Wu, Yang-Kui Gu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-7 (2023)
Abstract Hepatic arterial infusion chemotherapy (HAIC) using a combination of oxaliplatin, fluorouracil, and leucovorin (FOLFOX) has shown promise for hepatocellular carcinoma (HCC) patients classified under Barcelona Clinic Liver Cancer (BCLC) stage
Externí odkaz:
https://doaj.org/article/b8acba41e559430f803d5642c0d9caa6
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: An accumulating body of evidence suggests that long non-coding RNAs (lncRNAs) can serve as potential cancer prognostic factors. However, the utility of lncRNA combinations in estimating overall survival (OS) for hepatocellular carcinoma (
Externí odkaz:
https://doaj.org/article/e626c9f3ebb64ea68d6bfe612b6aaed5
Autor:
Qi-Feng Chen, Ning Lyu, Xun Wang, Xiong-Ying Jiang, Yue Hu, Song Chen, Sui-Xing Zhong, Zi-Lin Huang, Minshan Chen, Ming Zhao
Publikováno v:
International Journal of Surgery; Dec2023, Vol. 109 Issue 12, p3929-3939, 11p
Autor:
Qi-Feng Chen, Meng He, Ning Lyu, Xun Wang, Lin Dai, Xiong-Ying Jiang, Yue Hu, Zi-Lin Huang, Yao-Jun Zhang, Minshan Chen, Ming Zhao
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Hepatitis B virus, together with hepatitis C virus, has been recognized as the leading causes of hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) have been suggested in increasing studies to be the potential prognostic factor
Publikováno v:
Aging (Albany NY)
Alternative splicing events (ASEs) play a role in cancer development and progression. We investigated whether ASEs are prognostic for overall survival (OS) in hepatocellular carcinoma (HCC). RNA sequencing data was obtained for 343 patients included
Publikováno v:
Molecular and Clinical Oncology
Population-based study for predicting the prognosis for breast cancer liver metastasis (BCLM) is lacking at present. Therefore, the present study aimed to evaluate newly diagnosed BCLM patients of different tumor subtypes and assess potential prognos
Autor:
Yang-Kui Gu, Tian-Qi Zhang, Meng-Xuan Zuo, Zhi-Jun Geng, Ji-Bin Li, Zi-Lin Huang, Pei-Hong Wu
Publikováno v:
Journal of Clinical Oncology. 40:4106-4106
4106 Background: The combination of anti-angiogenesis and immune checkpoint blockade has been proven to improve clinical outcomes of advanced HCC. We assessed the efficacy and safety of HAIC combined with apatinib and camrelizumab for BCLC stage C HC
Publikováno v:
Oncology Letters.
N6-methyladenosine (m6A) RNA methylation, which is related to cancer initiation and progression, is dynamically regulated by the m6A RNA methylation regulators (including 'writers', 'erasers' and 'readers'). However, the prognostic value of m6A RNA m
Publikováno v:
Oncology Letters
N6-methyladenosine (m6A) RNA methylation, which is related to cancer initiation and progression, is dynamically regulated by the m6A RNA methylation regulators (including ‘writers’, ‘erasers’ and ‘readers’). However, the prognostic value